946 related articles for article (PubMed ID: 33860832)
1. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
Kong C; Zhao Z; Chen W; Lv X; Shu G; Ye M; Song J; Ying X; Weng Q; Weng W; Fang S; Chen M; Tu J; Ji J
Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
[TBL] [Abstract][Full Text] [Related]
2. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
Niu XK; He XF
World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
[TBL] [Abstract][Full Text] [Related]
3. A radiomics nomogram for predicting transcatheter arterial chemoembolization refractoriness of hepatocellular carcinoma without extrahepatic metastasis or macrovascular invasion.
Sheen H; Kim JS; Lee JK; Choi SY; Baek SY; Kim JY
Abdom Radiol (NY); 2021 Jun; 46(6):2839-2849. PubMed ID: 33388805
[TBL] [Abstract][Full Text] [Related]
4. A multi-institutional study to predict the benefits of DEB-TACE and molecular targeted agent sequential therapy in unresectable hepatocellular carcinoma using a radiological-clinical nomogram.
Liu K; Zheng X; Lu D; Tan Y; Hou C; Dai J; Shi W; Jiang B; Yao Y; Lu Y; Cao Q; Chen R; Zhang W; Xie J; Chen L; Jiang M; Zhang Z; Liu L; Liu J; Li J; Lv W; Wu X
Radiol Med; 2024 Jan; 129(1):14-28. PubMed ID: 37863847
[TBL] [Abstract][Full Text] [Related]
5. CT-based radiomics nomogram for prediction of survival after transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma and portal vein tumor thrombus.
Cheng S; Hu G; Jin Z; Wang Z; Xue H
Eur Radiol; 2023 Dec; 33(12):8715-8726. PubMed ID: 37436507
[TBL] [Abstract][Full Text] [Related]
6. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
[No Abstract] [Full Text] [Related]
7. Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma.
Zhao Y; Zhang J; Wang N; Xu Q; Liu Y; Liu J; Zhang Q; Zhang X; Chen A; Chen L; Sheng L; Song Q; Wang F; Guo Y; Liu A
BMC Cancer; 2023 Oct; 23(1):1026. PubMed ID: 37875815
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel combined nomogram model integrating Rad-score, age and ECOG to predict the survival of patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
Liu A; Liu B; Duan X; Yang B; Wang Y; Dong P; Zhou P
J Gastrointest Oncol; 2022 Aug; 13(4):1889-1897. PubMed ID: 36092317
[TBL] [Abstract][Full Text] [Related]
9. Radiomics nomogram for the prediction of microvascular invasion of HCC and patients' benefit from postoperative adjuvant TACE: a multi-center study.
Zhang K; Zhang L; Li WC; Xie SS; Cui YZ; Lin LY; Shen ZW; Zhang HM; Xia S; Ye ZX; He K; Shen W
Eur Radiol; 2023 Dec; 33(12):8936-8947. PubMed ID: 37368104
[TBL] [Abstract][Full Text] [Related]
10.
Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
[TBL] [Abstract][Full Text] [Related]
11. MRI-Based Radiomics: Nomograms predicting the short-term response after transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma patients with diameter less than 5 cm.
Kuang Y; Li R; Jia P; Ye W; Zhou R; Zhu R; Wang J; Lin S; Pang P; Ji W
Abdom Radiol (NY); 2021 Aug; 46(8):3772-3789. PubMed ID: 33713159
[TBL] [Abstract][Full Text] [Related]
12. Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score.
Zhao Y; Huang F; Liu S; Jian L; Xia X; Lin H; Liu J
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5181-5192. PubMed ID: 36369395
[TBL] [Abstract][Full Text] [Related]
13. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive assessment of response to transcatheter arterial chemoembolization for hepatocellular carcinoma with the deep neural networks-based radiomics nomogram.
Liu Y; Liu Z; Li X; Zhou W; Lin L; Chen X
Acta Radiol; 2024 Jun; 65(6):535-545. PubMed ID: 38489805
[TBL] [Abstract][Full Text] [Related]
15. Predicting the Outcome of Transcatheter Arterial Embolization Therapy for Unresectable Hepatocellular Carcinoma Based on Radiomics of Preoperative Multiparameter MRI.
Sun Y; Bai H; Xia W; Wang D; Zhou B; Zhao X; Yang G; Xu L; Zhang W; Liu P; Xu J; Meng S; Liu R; Gao X
J Magn Reson Imaging; 2020 Oct; 52(4):1083-1090. PubMed ID: 32233054
[TBL] [Abstract][Full Text] [Related]
16. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
17. Radiomics Signature: A potential biomarker for the prediction of survival in Advanced Hepatocellular Carcinoma.
Li L; Kan X; Zhao Y; Liang B; Ye T; Yang L; Zheng C
Int J Med Sci; 2021; 18(11):2276-2284. PubMed ID: 33967603
[No Abstract] [Full Text] [Related]
18. MRI-Based Radiomics: Associations With the Recurrence-Free Survival of Patients With Hepatocellular Carcinoma Treated With Conventional Transcatheter Arterial Chemoembolization.
Song W; Yu X; Guo D; Liu H; Tang Z; Liu X; Zhou J; Zhang H; Liu Y; Liu X
J Magn Reson Imaging; 2020 Aug; 52(2):461-473. PubMed ID: 31675174
[TBL] [Abstract][Full Text] [Related]
19. A radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma.
Zhu Y; Weng S; Li Y; Yan C; Ye R; Wen L; Zhou L; Gao L
Abdom Radiol (NY); 2021 Jul; 46(7):3139-3148. PubMed ID: 33641018
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Nomogram Incorporating Clinical Factors, Serological Markers and LI-RADS MRI Features to Predict Early Recurrence of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Sheng Y; Wang Q; Liu HF; Chen WH; He ZM; Wang Q
Acad Radiol; 2023 Jul; 30(7):1288-1297. PubMed ID: 36424310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
